CPNP Announcements
ONLY DAYS REMAIN FOR EARLY BIRD REGISTRATION RATES TO THE 2013 ANNUAL MEETING
Join hundreds of your colleagues in registering for the 2013 Annual Meeting to be held April 21–24 in Colorado Springs, Colorado. You can save over $100 on your registration fees by registering at early bird rates through March 20.
The Annual Meeting content and networking opportunities is proving to be just as committee members planned for—substantive and cutting-edge. If you are still evaluating the possibility of attending, here are just a few of the highlights for you to consider.
Daily Keynote Addresses From Nationally Recognized Speakers:



Citation: Mental Health Clinician 2, 9; 10.9740/mhc.n140745



Citation: Mental Health Clinician 2, 9; 10.9740/mhc.n140745



Citation: Mental Health Clinician 2, 9; 10.9740/mhc.n140745



Citation: Mental Health Clinician 2, 9; 10.9740/mhc.n140745
Pre-Meeting Workshop: A 3.5-hour training session with Shawn Shea, MD, entitled The Delicate Art of Uncovering Suicidal Ideation and Intent: The Chronological Assessment of Suicide Events (CASE Approach)
Cutting-Edge Programming: 28 hours of ACPE approved programming to choose from.
Research: Networking with over 130 poster authors along with exposure to 9 platform presentations to be presented by CPNP award finalists.
Act now to take advantage of this premier conference at reduced rates!
PREVIEW OF 2013 RESEARCH TRAINEE AND INNOVATIVE PRACTICES AWARD FINALIST
This edition of MHC features abstracts selected as 2013 Research Trainee and Innovative Practices award finalists. Award finalists will present their abstracts during the platform presentations on Monday, April 22, during the 2013 Annual Meeting. Winners for all categories will be announced on Tuesday, April 23. The next MHC will feature the Therapeutic Case Report, New Investigator, and Original Research award finalist abstracts. Browse all abstracts accepted for the meeting.
Research Trainee Award Finalists
2:00–2:15 p.m.: James Stevenson, PharmD, PGY Pharmacy Practice Resident, University of Illinois at Chicago, Chicago, IL Serotonin Transporter 5HTTLPR Polymorphism and Neurocognitive Outcomes in Lithium-Treated Pediatric and Adolescent Bipolar Disorder
2:15–2:30 p.m.: Katy Zeier, PharmD, PGY2 Psychiatric Pharmacy Resident, Chillicothe Veterans Affairs Medical Center, Chillicothe, OH A Retrospective Chart Review of a Symptom-Triggered Alcohol Withdrawal Protocol Versus Previous Standard of Care at a Veteran's Hospital
Innovative Practices Award Finalists
2:30–2:45 p.m.: Bethany DiPaula, PharmD, BCPP, Associate Professor, Director of Pharmacy, University of Maryland, Sykesville, MD Pharmacist-Physician Collaborative Care Model for Suboxone-Maintained Patients at a Health Department
2:45–3:00 p.m.: Kelly Williams, PharmD, BCPP, Clinical Pharmacy Specialist, Outpatient Psychiatry, Wishard Health Services/Midtown Community Mental Health Center, Indianapolis, IN Pharmacist-Managed Olanzapine Long-Acting Injection Clinic in A Community Mental Health Center
PRE-MEETING WORKSHOP FOCUSES ON CRITICAL ISSUE OF SUICIDE ASSESSMENT
Suicide is the headliner in many news stories today.
“US military veteran suicides rise, one dies every 65 minutes”
“Many stroke survivors think about suicide”
“Youth suicide rates under reported”
Suicide is the tenth leading cause of death in the United States,1 and is therefore an important topic for clinicians to focus on with a goal of preventing these acts. Ninety-five percent of completed suicides occur in patients with psychiatric disturbances including major depressive disorder, alcoholism, schizophrenia, severe borderline personality disorder, and frequent panic attacks. Psychosis has also been found to be a large risk factor for suicide.2 Other risk factors for suicidal ideation include patients with a lack of support system, organic impairment of sensorium, and illnesses leading to immobility or severe pain.2
Unfortunately, emphasis on interviewing and assessing for suicidal ideation is not a common component of pharmacy school curricula, nor is there a specific standard in residency accreditation for assessing suicidality. This is a skill often developed through clinical practice and special training sessions. Being the most accessible healthcare workers, it is important that pharmacists become comfortable and confident in the recognition of suicidality and in implementing prevention measures.
Offered Sunday, April 21 from 8–11:45 a.m., Dr. Shawn Shea's pre-meeting workshop on clinical interviewing for suicidal ideation is a great opportunity to gain the knowledge and skills needed to improve screening for suicidality. Utilizing an innovative interviewing strategy known for eliciting suicidal ideation, behaviors, and intent--the Chronological Assessment of Suicide Events or the CASE Approach-- The Delicate Art of Uncovering Suicidal Ideation and Intent workshop will provide a hands-on approach to learning and practicing the recommended interviewing strategies.
The workshop will start with a focus on the seven practical validity techniques, which form the cornerstones for effectively eliciting suicidal ideation: normalization, shame attenuation, the behavioral incident, gentle assumption, denial of the specific, the catch-all question, and symptom amplification. An internationally renowned innovator in the fields of suicide prevention and clinical interviewing, Dr. Shea demonstrates how these interviewing techniques can provide powerful gateways for uncovering the types of sensitive and taboo topics that may lead to suicidal thoughts including: physical abuse, drug abuse, antisocial behavior, and incest.
The workshop concludes with numerous demonstrations of how these validity techniques can be woven into a specific strategy to uncover suicidal ideation, behaviors, and intent using the CASE Approach. All interviewing techniques will be clearly demonstrated through active learning and the use of videotape examples from actual patient interviews.
Plan to take the advice of past attendees of this workshop and register now to attend this impactful event on Sunday, April 21 in Colorado Springs.
“After attending Dr. Shea's presentation last year, I continue to use several of his tips and tools. Students and residents have been interested in learning and using these techniques as well.” Carla Cobb, PharmD, BCPP
“The CASE Approach moves the clinician almost imperceptibly into the secret internal workings of the mind and soul of the patient tormented by suicidal ideation. I believe that the CASE Approach is a remarkable conceptual and clinical contribution to the field of suicidology. It should be taught to any front-line clinician. It has the power to meaningfully save lives.” David Jobes, PhD, Past President, American Association of Suicidology
”The CASE Approach provides a strikingly graceful and sensitive way to actively explore the client's hidden world of suicidal ideation and intent. In over 30 years of training psychologists, social workers, and psychiatric residents it is, without a doubt, the most practical and engaging clinical strategy I have ever passed on to my students. I am convinced it will save lives.” Bruce Baker, D.Ed.



